Roche Holding AG (SWX:ROG)
307.00
+4.30 (1.42%)
Mar 7, 2025, 5:31 PM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
604.32K CHF
Profits / Employee
80.17K CHF
Market Cap
245.96B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 103,249 | -356 | -0.34% |
Dec 31, 2023 | 103,605 | -8 | -0.01% |
Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
Dec 31, 2021 | 100,920 | -545 | -0.54% |
Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Novartis AG | 75,883 |
Lonza Group AG | 18,686 |
Alcon | 25,599 |
Galderma Group AG | 6,545 |
Straumann Holding AG | 11,815 |
Sandoz Group AG | 22,633 |
Sonova Holding AG | 18,151 |
Ypsomed Holding AG | 2,296 |
Roche Holding AG News
- 3 days ago - Roche announces launch of Roche Genentech Innovation Center Boston based at Harvard's Enterprise Research Campus in Allston - GlobeNewsWire
- 4 days ago - Noted Family Office Leader Stephan Roche Joins BanyanGlobal Family Business Advisors Partnership Group - Business Wire
- 4 days ago - Illumina: Navigating Headwinds As China Bans Instruments And Roche Enters The NGS Race - Seeking Alpha
- 5 days ago - FDA Accepts Supplemental Biologics License Application for Genentech's Gazyva for the Treatment of Lupus Nephritis - Benzinga
- 5 days ago - FDA accepts supplemental Biologics License Application for Roche's Gazyva/Gazyvaro for the treatment of lupus nephritis - GlobeNewsWire
- 5 days ago - FDA Accepts Supplemental Biologics License Application for Genentech's Gazyva for the Treatment of Lupus Nephritis - Business Wire
- 6 days ago - FDA Approves Genentech's TNKase® in Acute Ischemic Stroke in Adults - Business Wire
- 6 days ago - Roche Touts Food Allergy Drug As Superior Than Oral Immunotherapy - Benzinga